Journals / Ulusal Romatoloji Dergisi / 2020 / Cilt: 12 - Sayı: 1

Frequency of lost to follow-up of rheumatoid arthritis and ankylosing spondylitis patients in a tertiary center

Tersiyer bir merkezde romatoid artrit ve ankilozan spondilit hastalarının takipten çıkma sıklığı

Pages
7–11
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The presence of patients who did not come to follow-up due to the absence of complaint indicates that patients should be informed about the importance of regular follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are one of the most common rheumatologic diseases.
📊
Key Findings & Data:Methods: Patients who were diagnosed as RA and AS in 2010 were included.
💡
Conclusion & Impact:The presence of patients who did not come to follow-up due to the absence of complaint indicates that patients should be informed about the importance of regular follow-up.
🔬Design:Review & Systematic Survey
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are one of the most common rheumatologic diseases. Physical disability can be prevented by controlling disease activity. For this purpose, patients need to attend regular follow-up appointments. We aimed to determine the frequency of lost-to follow-up in RA and AS patients and to find out the magnitude of this problem. Methods: Patients who were diagnosed as RA and AS in 2010 were included. Patients files were reviewed and patients who did not attend the follow-up appointments were called. After verbal consent was obtained, reasons for not coming back to the appointment were noted. Results: There were 314 RA and 191 AS patients. The frequencies of the regular follow-up were 44% in RA and 43% in AS patients. 32% of RA and 30% of AS patients could not be contacted. Among the patients who were lost-to-follow-up, 72% of RA and 70% of AS patients had only one visit. The most common reason of nonadherence with recommended follow-up visit was being followedup in another center for RA (65%) and having no complaints for AS patients (54%). Conclusion: Although approximately 40% of AS and RA patients were lost to follow-up at the end of 8 years, a significant proportion of these patients have been following in other centers. The presence of patients who did not come to follow-up due to the absence of complaint indicates that patients should be informed about the importance of regular follow-up.

Özet

Amaç: Romatoid artrit (RA) ve ankilozan spondilit (AS) en sık görülen romatolojik hastalardan ikisidir. Hastalık aktivitesinin kontrolü ile fiziksel yeti yitimi önlenebilmekte ve bunun için de hastaların takiplerine düzenli gelmeleri gerekmektedir. Biz bu çalışmada AS ve RA hastalarının ne kadarının takipten çıktığını saptayarak bu problemin büyüklüğünü ortaya çıkarmayı amaçladık. Yöntem: Kayıt kütüğümüzde 2010 yılında RA ve AS tanısı ile dosya açılmış hastalar çalışmaya dahil edildi. Hasta dosyalarına bakılarak kontrol muayenelerine gelmeyen hastalar telefonla arandı. Çalışmanın amacı anlatılarak onam alındıktan sonra hastalara neden kontrollerine gelmedikleri soruldu. Bulgular: 2010 yılında kayıt kütüğümüze kaydedilmiş olan 314 RA ve 191 AS hastasının dosyası incelendi. Takipten çıkma oranı RA hastalarında %44, AS hastalarında ise %43 idi. RA hastalarının %32’sine AS hastalarının ise %30’una ulaşılamadı. Ulaşılamayan hastaların sadece bir kez kliniğimize gelme oranı RA’da %72, AS’de %70 idi. Ulaşılabilen hastaların kontrole gelmemelerinin en sık sebebi RA hastalarında başka bir merkezde takip edilmeleri (%65) AS hastalarında ise yakınmalarının olmaması (%54) idi. Sonuç: Sekiz yılın sonunda AS ve RA hastalarının yaklaşık %40’ı takipten çıkmış olsa da bu hastaların önemli bir bölümü başka merkezlerde takip edilmekteydi. Yakınması olmadığı için takibe gelmeyen hastaların varlığı ise düzenli takibin önemi konusunda bilgilendirmenin önemine işaret etmektedir.

🔖

Cite This Article

UĞURLU, S., ESATOĞLU, S. N., ÇELİK, F., YEŞİLSANCAK, M., DOYMAZ, F. (2022). Frequency of lost to follow-up of rheumatoid arthritis and ankylosing spondylitis patients in a tertiary center. Ulusal Romatoloji Dergisi, Cilt: 12 - Sayı: 1, 7–11. https://ajindex.com/articles/643901

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O, et al. Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of izmir, turkey. J Rheumatol 2008;35:305-9
  2. Maksymowych WP, Brown MA. Genetics of ankylosing spondylitis and rheumatoid arthritis: Where are we at currently, and how do they compare? Clin Exp Rheumatol 2009;27:S20-5
  3. Jacobs P, Bissonnette R, Guenther LC. Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability. J Rheumatol Suppl 2011;88:55-61
  4. Kobelt G, Lindgren P, Lindroth Y, Jacobson L, Eberhardt K. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis. Rheumatology (Oxford) 2005;44:1169-75
  5. Akkoc N, Direskeneli H, Erdem H, Gul A, Kabasakal Y, Kiraz S, et al. Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in turkey. Rheumatol Int 2015;35:1473-8
  6. Hamuryudan V, Direskeneli H, Ertenli I, Inanc M, Karaaslan Y, Oksel F, et al. Direct and indirect healthcare costs of rheumatoid arthritis patients in turkey. Clin Exp Rheumatol 2016;34:1033-7
  7. Pincus T, Braun J, Kavanaugh A, Smolen JS. Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist. Clin Exp Rheumatol 2013;31:S1-3
  8. Van Cutsem G, Ford N, Hildebrand K, Goemaere E, Mathee S, Abrahams M, et al. Correcting for mortality among patients lost to follow up on antiretroviral therapy in south africa: A cohort analysis. PLoS One 2011;6:e14684
  9. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
  10. Glave-Testino C, Cardiel MH, Arce-Salinas A, Alarcon-Segovia D. Factors associated with disease severity in mexican patients with rheumatoid arthritis. Clin Exp Rheumatol 1994;12:589-94
  11. Uribe AG, Ho KT, Agee B, McGwin G, Jr., Fessler BJ, Bastian HM, et al. Relationship between adherence to study and clinic visits in systemic lupus erythematosus patients: Data from the lumina cohort. Lupus 2004;13:561-8
  12. Tien YC, Chiu YM, Liu MP. Frequency of lost to follow-up and associated factors for patients with rheumatic diseases. PLoS One 2016;11:e0150816
  13. Bertoli AM, Fernandez M, Calvo-Alen J, Vila LM, Sanchez ML, Reveille JD, et al. Systemic lupus erythematosus in a multiethnic u.S. Cohort (lumina) xxxi: Factors associated with patients being lost to follow-up.